Asymmetric dimethyl arginine as a cardiovascular risk marker in patients with hyperthyroidism: a randomised case control study in a tertiary level health care centre

Journal Title: International Journal of Clinical Biochemistry and Research - Year 2017, Vol 4, Issue 1

Abstract

Background: Cardiovascular manifestations are frequent findings in patients with thyroid hormone disorders. Asymmetric dimethylarginine (ADMA), a inhibitor of endothelial nitric oxide synthase (eNOS), blocks nitric oxide (NO) synthesis from l-arginine. So, ADMA level can be considered as cardiovascular risk marker as it is a possible contributing factors for endothelial dysfunction in hyperthyroid patients. Objectives: The aim of the study was to assess ADMA levels in hyperthyroidism patients free of cardiovascular risk associates and further comparison with healthy controls. Methodology: The study took place in Victoria Hospital, attached to Bangalore Medical College and Research Institute. The study groups consisted of 30 patients with diagnosed hyperthyroidism and 30 healthy sex and age matched controls. The patients with renal failure, diabetes and severe hypertension were excluded. ADMA was estimated by double-antibody sandwich enzyme-linked immunosorbent assay (ELISA). Results: The Mean ADMA level was higher in the hyperthyroid group (1.1346±0.6382μmol/L) than in the control group (0.584±0.2377μmol/L) and it was statistically significant (p<0.0001). Conclusion: ADMA represents a new and well-characterized marker that has been associated with many traditional and novel risk factors in the setting of cardiovascular risk. So, an elevation of ADMA levels of patients with hyperthyroidism compared with healthy controls may contribute to some cardiovascular alterations.

Authors and Affiliations

Priyanka Patra, Anitha M. , HL Vishwanath

Keywords

Related Articles

To study biochemical markers in chronic obstructive pulmonary disease patients

Introduction Chronic obstructive pulmonary disease COPD which includes chronic bronchitis and emphysema is considered as a progressive type of respiratory tract disease and is characterized by structural changes such as...

Biochemical Profile of women with pregnancy induced hypertension

Background: Hypertensive disorders complicating pregnancy are common and form one of the deadly triad, along with hemorrhage and infection. Pre-eclampsia is a syndrome of generalized endothelial dysfunction initiated by...

Analysis of serum ferritin levels in non-diabetic, prediabetic and diabetic individuals

Introduction: Type 2 diabetes mellitus (T2DM) is characterized by impaired insulin secretion, insulin resistance or both. In the initial asymptomatic phase there is hyperinsulinemia, as insulin resistance progress and be...

A study on estimation of serum ferritin in type 2 diabetes mellitus cases on oral hypoglycemic agents

Introduction: Diabetes mellitus is a metabolic disorder characterized by hyperglycemia and associated micro and macro vascular complications on long duration. Insulin resistance is associated with onset of type 2 DM and...

Assessment of Vitamin D status in Type 1 Diabetes Mellitus in pediatric age group

Background: Diabetes mellitus is a group of metabolic disorders characterized by hyperglycemia. Type-1-Diabetes Mellitus (TIDM) results from autoimmune destruction of beta cells leading to insulin deficiency. Vitamin D d...

Download PDF file
  • EP ID EP295935
  • DOI 10.18231/2394-6377.2017.0023
  • Views 83
  • Downloads 0

How To Cite

Priyanka Patra, Anitha M. , HL Vishwanath (2017). Asymmetric dimethyl arginine as a cardiovascular risk marker in patients with hyperthyroidism: a randomised case control study in a tertiary level health care centre. International Journal of Clinical Biochemistry and Research, 4(1), 99-102. https://europub.co.uk./articles/-A-295935